ArticleMolecular oncology2025

Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in arm A of the NSGO-OV-UMB1/ENGOT-OV30 trial.

Luka Tandaric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.